Pfizer will dominate $28 billion COVID-pill market in 2022

With the rapid spread of Omicron across the globe and the strong reluctance from Governments to shut down again, it will be interesting to see how quickly a Covid tablet will become available on mass.

Pfizer is tipped by a few different sources to be the likely one to take the lead.

Share price looks too hot at the moment so will keep an eye on it for a pullback.

Strong run at the moment.

Komen:

Link to article: www.smh.com.au/busin...20211217-p59ibs.html

Komen:

Price has as expected pulled back into a better value area and one where importantly it has bounced off its 20 Day Moving Average previously - so have started to keep an eye on it again. Keep an eye out for the bounce.